NAPROXEN
- Product NDC
- 50436-0618
- 11-digit product format
- 504360618
- Labeler code
- 50436
- Product ID
- 50436-0618_6d262080-c732-4e93-b045-944c721f6e9c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2016-07-06
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50436-0618-1 | NAPROXEN | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
| 50436-0618-2 | NAPROXEN | 60 in 1 BOTTLE | TABLET | 60 | | 2 |
| 50436-0618-3 | NAPROXEN | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50436-0618 | NAPROXEN TABLET [UNIT DOSE SERVICES] | 2 | Legacy NDC, 3 package rows | 20210919_1f416e0b-378b-4514-9b8e-7d8cce766d91.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50436-0618-1 | 50436061801 | 30 TABLET in 1 BOTTLE (50436-0618-1) | 30 tablet | 2021-09-17 | 0000-00-00 | No | No | Current |
| 50436-0618-2 | 50436061802 | 60 TABLET in 1 BOTTLE (50436-0618-2) | 60 tablet | 2021-09-17 | 0000-00-00 | No | No | Current |
| 50436-0618-3 | 50436061803 | 90 TABLET in 1 BOTTLE (50436-0618-3) | 90 tablet | 2021-09-17 | 0000-00-00 | No | No | Current |